Le Lézard
Classified in: Business
Subject: ATY

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MacroGenics, Inc. - MGNX


NEW YORK, June 24, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of MacroGenics, Inc. ("MacroGenics" or the "Company") (NASDAQ: MGNX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

The investigation concerns whether MacroGenics and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

[Click here for information about joining the class action] 

On April 3, 2024, MacroGenics announced Phase 2 TAMARACK interim safety data as contained in its abstract submitted to the American Society of Clinical Oncology on February 6, 2024. The Company reported that "[p]reliminary safety data from TAMARACK suggest that reducing the dose and frequency of vobra duo improves its safety and tolerability in men with mCRPC." Then, on May 10, 2024, MacroGenics revealed that five patients in the TAMARACK study had died. 

On this news, MacroGenics' stock price fell $11.36 per share, or 77.4%, to close at $3.31 per share on May 10, 2024.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered billions of dollars in damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes.  

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980

SOURCE Pomerantz LLP


These press releases may also interest you

at 04:00
The DJS Law Group reminds investors of a class action lawsuit against Biogen Inc. ("Biogen" or "the Company")  for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and...

at 04:00
The 2nd stage of construction of the NINE by Mirvac residential development in Willoughby (NSW),...

at 04:00
Workday, Inc , a leading provider of solutions to help organisations manage their people and money, today published The UK Productivity Gap: How AI can unlock workplace potential, a new report discovering the positive economic impact artificial...

at 04:00
Webull UK, a leading digital investment platform, today announced the launch of Webull Savings, an offering that provides users with access to a marketplace of savings accounts and the ability to move funds quickly between trading accounts and banks....

at 03:39
Developed and manufactured by leading Chinese heavy equipment manufacturer SANY Group ("SANY"), the world-class 408P electric mixer truck has recently passed the updated EU General Safety Regulation (GSR) benchmark. Equipped with advanced...

at 03:34
GAMAYA and Terraview have announced their merger, combining their AI-powered platforms to enhance sustainability and climate-resiliency in global food production. This strategic move aims to address decarbonization and water...



News published on and distributed by: